How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial

March 23, 2017

Other than skin cancer, prostate cancer is the most common cancer in American men with about one in seven receiving a prostate cancer diagnosis during his lifetime.

Spotlight

Accutest Research Laboratories (I) Pvt. Ltd.

Accutest is a global independent and internationally accredited Contract Research Organisation ("CRO") founded in 1998. We are offering services to customers around the world with operations in India and Brazil. Accutest is the market leader amongst independent CROs, with the highest quality standards and quick turnaround time. We have a strong regulatory track record of 80+ accreditations/approvals from global regulatory agencies.

OTHER WHITEPAPERS
news image

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More
news image

Helping Patients Find and Engage with Clinical Trials

whitePaper | June 16, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible

Read More
news image

Characterization of Protein Aggregates and Other Particles in Biopharmaceuticals

whitePaper | July 8, 2022

Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production1–3. These particles must be monitored to satisfy.

Read More
news image

Benefits of Semantic Enrichment Across the Drug Development Pipeline

whitePaper | January 24, 2022

Semantics is the process of assigning meaning to words and is a vital step in making unstructured scientific content machine readable, contextualizing otherwise unstructured information. It unlocks a host of benefits to search and analytics which are outlined below in the context of use cases relevant to drug discovery.

Read More
news image

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

Read More
news image

Pharma 2020: Marketing the future. Which path will you take?

whitePaper | August 8, 2021

If Pharma is to create a new marketing and sales model that is fit for 2020, it will have to begin by analysing its own value chain to identify opportunities for working more closely with healthcare payers and providers. It will, for example, have to collaborate much more closely with payers (be they governments, health insurers, employers or patients) to ensure that it develops medicines which have real social and economic value.

Read More

Spotlight

Accutest Research Laboratories (I) Pvt. Ltd.

Accutest is a global independent and internationally accredited Contract Research Organisation ("CRO") founded in 1998. We are offering services to customers around the world with operations in India and Brazil. Accutest is the market leader amongst independent CROs, with the highest quality standards and quick turnaround time. We have a strong regulatory track record of 80+ accreditations/approvals from global regulatory agencies.

Events